Glaucoma has a habit of hiding in plain sight. Most people who walk into an optometry clinic for a routine visit are thinking about their prescription, dry eyes, headaches, or whether their vision has changed enough to justify new glasses. Glaucoma is usually not on their radar, and that is part of the problem. By the time someone notices missing patches in peripheral vision, the disease may already have caused damage that cannot be reversed.
That is why a careful glaucoma eye exam matters so much. Optometrists are trained to look for the earliest signs that pressure, optic nerve structure, or visual function may be changing. In a single routine exam, they are often gathering clues from several different angles, some clinical, some imaging based, and some based on how a patient responds to testing. A glaucoma screening is rarely one dramatic moment. It is more like assembling a case from small, meaningful pieces.
What optometrists are looking for
Glaucoma is not one disease with one signature. It is a group of optic neuropathies, and the common thread is damage to the optic nerve, often associated with elevated eye pressure, though not always. That distinction matters. Plenty of people have high eye pressure and never develop glaucoma. Others develop the disease despite pressures that appear normal. So the optometrist is not simply asking, “Is the pressure high?” The real question is, “Does the optic nerve look vulnerable, and is there any sign it is already being injured?”
During a routine exam, the optometrist looks at three broad areas. First, they assess eye pressure and the structures that affect drainage. Second, they examine the optic nerve itself, often with dilation or imaging. Third, they test whether any functional loss has already occurred, usually with a visual field test if the case warrants it. Those pieces, combined with age, family history, corneal thickness, medical history, and race or ethnicity in some contexts, help shape risk.
Some patients are surprised to learn that glaucoma screening is often less about one perfect test and more about pattern recognition over time. That is true. A single normal result does not always rule out disease, and a borderline result does not always mean glaucoma. What matters is whether the findings make sense together.
The first clues often begin before the exam itself
A good glaucoma screening begins with conversation. The optometrist usually asks about family history, because glaucoma does cluster in families. A parent or sibling with the disease raises concern. Age matters too. Risk rises with advancing years, especially after age 40, though glaucoma can affect younger adults and even children in some forms. Some systemic conditions, such as diabetes and severe myopia, can also increase suspicion.
Medication history can matter more than people realize. Steroid use, whether in eye drops, inhalers, skin creams, or pills, can raise eye pressure in susceptible patients. That is one of those details patients often do not think to mention unless asked directly. I have seen people come in for what they thought was a standard checkup, only to remember Check out this site mid-conversation that they had been using steroid drops for months after an eye allergy flare. That detail changes how you interpret the rest of the exam.
Symptoms are less helpful than many assume. Classic glaucoma can progress with no pain and no obvious visual complaints. Still, patients sometimes mention subtle issues like bumping into doorframes, trouble seeing in dim light, or needing more light for reading. Those symptoms are not specific to glaucoma, but they can push an optometrist to look more closely.
Measuring eye pressure is important, but it is only one piece
Tonometry, the measurement of intraocular pressure, is usually part of a routine eye exam. Most clinics use either a non-contact method, often called the air puff test, or a contact device that measures pressure more directly. The number itself is useful, but not absolute. A pressure in the high teens may be perfectly fine for one person and concerning for another. A pressure in the low 20s may prompt a closer look, especially if there are other suspicious findings.
The cornea influences pressure readings. A thick cornea can make the pressure seem higher than it truly is, while a thin cornea can make it seem lower. That is why many optometrists measure corneal thickness with pachymetry when glaucoma is suspected or when a patient is being followed for risk. It gives context to the pressure number instead of treating it like a standalone verdict.
Eye pressure also fluctuates through the day. A patient can have a normal reading in the morning and a higher one later. Because of that, optometrists interpret pressure as part of a pattern, not a one-time judgment. If the optic nerve looks healthy, the fields are normal, and the pressure is modestly elevated, the plan may be observation and repeat testing rather than immediate treatment. If the nerve already shows cupping or asymmetry, the same pressure reading becomes more worrisome.
Looking directly at the optic nerve
The optic nerve is where glaucoma leaves its fingerprints. During the exam, the optometrist examines the optic nerve head, either through a dilated view or with imaging. They are looking for cupping, asymmetry between the two eyes, thinning of the neuroretinal rim, notching, disc hemorrhages, and other subtle structural changes.
Cupping is one of the better-known features, but it is easy to oversimplify. Some people naturally have large optic nerve cups without disease. Others have smaller discs where a bit of cupping looks more dramatic. This is why comparison between both eyes matters so much. A substantial difference in cup-to-disc ratio between eyes can be a red flag, especially if the rest of the exam supports it.
Optometrists also pay attention to nerve fiber layer appearance. With dilation, they may spot shallow losses or localized thinning. Small disc hemorrhages can be important, particularly in normal-tension glaucoma or in patients whose disease seems to progress despite not especially high pressure. Those are the findings that make a screening feel more like detective work than routine optics.
Why retinal imaging has become such a valuable part of screening
Retinal imaging glaucoma assessment is now common in many practices, and for good reason. A high-quality image of the optic nerve and surrounding retina lets the optometrist document what the nerve looks like today and compare it with future visits. That baseline is often more valuable than patients realize.
Imaging can capture details the examiner may not fully appreciate through a quick ophthalmoscopic look, especially when the pupil is small or the view is limited. It also helps with patient education. Showing someone the image of their own optic nerve, rather than describing it abstractly, can make the discussion more concrete. Patients often understand the concern faster when they can see asymmetry or thinning.
That said, retinal imaging is not magic. It supplements the exam, it does not replace clinical judgment. A very good image can still miss functional loss, and a suspicious image may turn out to be a stable anatomical variant. The value is in consistency and comparison. When the same eye is imaged over multiple visits, even small changes can become apparent.
The role of OCT in glaucoma screening
The OCT scan glaucoma test has changed everyday practice in a major way. OCT, or optical coherence tomography, provides cross-sectional images of the retina and optic nerve region. In practical terms, it allows the optometrist to measure the retinal nerve fiber layer and, in many cases, the ganglion cell complex, both of which can thin before noticeable vision loss occurs.
This is one of the reasons OCT is so useful in a glaucoma eye exam. Visual field defects often lag behind structural damage. The eye can lose nerve tissue before the patient notices missing vision. OCT helps catch those structural changes earlier than relying on symptoms alone. It is especially useful when the optic nerve looks suspicious but the visual field is still normal, or when the opposite is true and the field suggests a defect that needs anatomical confirmation.
OCT interpretation requires judgment. A thin nerve fiber layer does not automatically mean glaucoma. Myopic eyes can produce misleading measurements. Segmentation errors can distort results. Motion during the scan, poor fixation, or media opacity like cataract can reduce reliability. A skilled optometrist does not just glance at the color coding and call it a day. They check the raw data, compare the scan with the patient’s anatomy, and ask whether the numbers fit the full picture.
For many patients, OCT also serves as a baseline. If the scan is normal today, that still matters. It creates a reference point for the future. If the patient later develops a borderline field change or a pressure rise, the clinician can compare old and new scans to see whether there is true progression.
Why a visual field test still matters
Even in an era full of imaging, the visual field test remains essential. Glaucoma is a disease of function as much as structure. The eye can have a suspicious-looking nerve on OCT or exam, but if the visual field remains stable over time, the risk profile may be different than if field defects are appearing or worsening.
The test itself can feel tedious. Patients sit with one eye covered and press a button when they see lights flash in different parts of the visual field. Some lights are bright and easy to detect. Others are faint and brief. The challenge is to stay attentive and avoid chasing phantom lights. The test rewards patience more than speed.
A single visual field test is not enough to diagnose glaucoma in many cases. Fatigue, inexperience, dry eyes, poor fixation, or anxiety can create noisy results. That is why optometrists often repeat the test if the first one looks suspicious. They are looking for reproducible patterns, such as arcuate defects or nasal step changes, that match the anatomy of the optic nerve.
For patients, the visual field test is often the least favorite part of the visit, but it is one of the most revealing. It can pick up functional damage that imaging has not yet clearly documented, and it is central to monitoring progression over time. In many practices, it becomes part of the long-term story of the patient’s eyes.
How optometrists decide whether something is just a risk factor or actual glaucoma
This is where experience matters. A routine exam can uncover a dozen small concerns, but not all of them are disease. An optometrist has to decide whether the patient has glaucoma, is a glaucoma suspect, or simply needs routine follow-up.
A suspicious optic nerve with normal pressure and normal fields may lead to closer observation, more testing, or referral depending on the level of concern. Elevated pressure with healthy nerves and normal fields may also be watched carefully, especially if corneal thickness is reassuring and there is no family history. Structural change on OCT that matches a field defect usually raises the level of concern more quickly. The combination matters more than any one test.
Sometimes the best call is to repeat testing before labeling a patient. That is not indecision, it is good medicine. Eye tests are affected by momentary factors, and glaucoma progresses slowly enough that there is usually time to verify a borderline result. On the other hand, if the optic nerve looks clearly damaged or if the field defect is convincing, the optometrist may move faster and discuss treatment or referral to an ophthalmologist.
A typical screening sequence in the clinic
Most patients do not move through glaucoma screening in a dramatic, separate appointment. It is usually folded into a regular comprehensive exam. The process often starts with history, pressure measurement, and a quick look at the front and back of the eye. If anything raises suspicion, the optometrist may dilate the eyes, perform OCT, capture retinal imaging glaucoma photos, and arrange a visual field test either the same day or at a follow-up visit.
The sequence can vary by clinic and by the patient’s risk level. Someone with strong family history and borderline pressures may get a more detailed workup on the spot. Someone with no risk factors and a healthy optic nerve may not need advanced testing during every annual visit. That is normal. Screening should be proportional, not automatic for the sake of it.
A practical way to think about the process is this:
The optometrist gathers risk information and checks eye pressure. The optic nerve is examined for structural signs of damage. Imaging such as OCT or retinal photographs is used to document the nerve. A visual field test is ordered if the exam suggests possible functional loss. The results are compared over time to determine whether the pattern is stable or changing.That sequence sounds simple, but each step carries nuance. The optometrist is not just collecting data. They are trying to determine whether the eye is stable enough to monitor or concerning enough to treat or refer.
Why early screening changes outcomes
Glaucoma damage cannot be reversed. That sentence sounds stark because it is. Once nerve fibers are gone, they do not regenerate in any clinically meaningful way. The goal of screening is to find disease early enough that treatment can slow or halt further loss. That is the entire logic behind careful routine exams.
Early detection matters most because glaucoma often steals side vision first. People can adapt to slow changes remarkably well. They turn their heads more often, drive a little more cautiously, or attribute missed steps to distraction. By the time the problem becomes obvious, the disease may already have been quietly progressing for years.
When caught early, many patients do quite well with monitoring, pressure-lowering drops, laser treatment, or referral for specialist care if needed. The details depend on the type and severity of glaucoma, but the common theme is preserving what vision remains. Screening is the front line of that effort.
What patients can do to make the exam more useful
Patients are not passive in this process. The most helpful thing they can do is share accurate history, especially family history, steroid exposure, and any prior eye records. Bringing old prescriptions, previous test results, or the name of a former eye doctor can save time and help the optometrist spot trends.
It also helps to describe symptoms honestly, even if they seem vague. “I just feel like my vision is off” is worth saying. So is “I can’t tell whether this is just my glasses or something else.” Optometrists spend a lot of time sorting out exactly that kind of uncertainty.
On the testing side, concentration matters. For the visual field test, it helps to relax and respond naturally rather than trying to anticipate lights. For OCT and imaging, keeping still and following fixation cues improves quality. These may sound like small things, but they can be the difference between a clean baseline and a confusing artifact.
When screening becomes referral
If a routine exam reveals likely glaucoma or a high-risk suspect state, the optometrist may begin treatment within their scope or refer to an ophthalmologist, depending on the practice setting and the complexity of the case. Referral is more likely when there are advanced field defects, rapidly changing OCT findings, very high pressures, unusual anatomy, or uncertainty about the diagnosis.
That handoff is not a failure of the exam. It is often the right next step. Glaucoma care can require coordination, especially when surgery, laser procedures, or more advanced monitoring are needed. The important part is that the screening has done its job: it has identified a problem before the patient lost more vision than necessary.
Routine exams are often where glaucoma is first suspected, and that is exactly why they matter. A pressure check, a careful look at the optic nerve, retinal imaging glaucoma photos, an OCT scan glaucoma assessment, and a visual field test can together reveal a disease that otherwise would stay silent for far too long. The best screenings are not flashy. They are steady, thorough, and built on the kind of small observations that accumulate into a clear clinical picture.
For patients, the message is straightforward. A glaucoma eye exam is not just about whether you need glasses changed. It is also one of the most important opportunities to protect sight for the long term, especially when the disease has not yet made itself obvious.
Opticore Optometry Group, PC - BUENA PARK, CA
8301 La Palma Ave #400, Buena Park, CA 90620Phone: (562) 312-3262
Website: opticoreyegroup.com/buena-park.html